Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01F
- Chemical subgroupJ01FA
- Chemical substanceJ01FA01Erythromycin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 81 registrations
- Erythrocin I.V.500 MG / VIAL · Powder For Solution · Amdipharm Limited
- Erythrocin I.V.1 G / VIAL · Powder For Solution · Amdipharm Limited
- Erythromycin5 MG / G · Ointment · Pharma Stulln INC.
- Erythromycin Ophthalmic Ointment USP5 MG / G · Ointment · Steri-Med Pharma INC.
United States
FDA · 80 registrations



